Results 121 to 130 of about 25,663 (196)

<i>In vitro</i> activity of aztreonam-avibactam and comparators against <i>Enterobacterales</i> isolated from bloodstream infections: ATLAS/ surveillance, 2021-2022. [PDF]

Microbiol Spectr
Rossolini GM, Hu F, Sethuraman N, Kamat S, Mohamed N, Stone G, Perez KK.   +6 more
europepmc   +1 more source

Detection of carbapenem resistance mechanisms in difficult-to-treat Pseudomonas aeruginosa clinical isolates from a tertiary care hospital in Egypt. [PDF]

BMC Microbiol
Salem D, Zaiton M, El-Shenawy A, Dahroug H, El-Dein S, Gamal D, Althoqapy AA, Mohamed AA, Shemis MA, Diab M, Maklad SS.   +10 more
europepmc   +1 more source

<i>In vitro</i> activity of aztreonam-nacubactam and cefepime-nacubactam against a global collection of clinically important Gram-negative Bacilli collected in 2021-2023. [PDF]

JAC Antimicrob Resist
Karlowsky JA, Estabrook M, Suzuki E, Shimizu A, Okade H.   +4 more
europepmc   +1 more source

<i>In vitro</i> susceptibility of <i>Stenotrophomonas maltophilia</i> and other carbapenem non-susceptible Gram-negative rods in the Pacific Northwest to cefiderocol and aztreonam-avibactam. [PDF]

JAC Antimicrob Resist
Bryan A, Shields-Pruiett M, Berger H, Fang FC, Penewit K, Waalkes A, Holmes EA, Salipante SJ, Werth BJ.   +8 more
europepmc   +1 more source

Emergence of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae with Penicillin-Binding Protein 3 Insertions, Taiwan, 2021. [PDF]

Emerg Infect Dis
Long T, Lovey A, Sanborn L, Zhao Y, Bulman ZP, Lin YT, Chen L.   +6 more
europepmc   +1 more source

Emergence of a novel NDM-4-producing <i>Citrobacter freundii</i> complex species in a complicated urinary tract infection treated with cefiderocol. [PDF]

IDCases
Boehm C, Dingle TC, Croxen MA, Lynch T, Church D.   +4 more
europepmc   +1 more source

ADVANCE-ID bacterial and fungal infections review: antimicrobial resistance research updates. [PDF]

JAC Antimicrob Resist
Manesh A, Mo Y, Wang J, Paterson DL.
europepmc   +1 more source

Evaluation of drug-drug interaction between nacubactam and β-lactam antibiotic (cefepime, aztreonam, meropenem, or piperacillin) in Japanese healthy participants. [PDF]

Antimicrob Agents Chemother
Morita J, Sato H, Sumiya M, Takaya R, Ishiwata K, Matsumoto S, Yonemura T, Kumagai Y.   +7 more
europepmc   +1 more source

Prevalence and Antimicrobial Resistance of <i>Pseudomonas aeruginosa</i> Recovered from Respiratory and Urinary Specimens in a Lebanese Hospital (2020-2025). [PDF]

Infect Dis Rep
Barakat R, Ezzeddine Z, El Haidari R, Hassan S, Ghssein G.   +4 more
europepmc   +1 more source

Comparison of laboratory-developed methods for aztreonam plus ceftazidime-avibactam antimicrobial susceptibility testing for metallo-beta-lactamase-producing Enterobacterales. [PDF]

J Clin Microbiol
Bhatnagar AS, Harris H, Jacobs E, Bumpus-White P, Balbuena R, Stambaugh H, Crayton K, Haynie J, Quintero Ilutsik J, Longo C, Bergman Y, Singh S, Murray M, Sabour S, Robinson ML, Machado M-J, Simner PJ.   +16 more
europepmc   +1 more source